TRACON Pharmaceuticals Inc

Market cap: $107,390,622

Exchange: NAS

Sector: Health Technology

Share
Tweet

TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, ophthalmic, and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types; TRC205 created for the treatment of fibrotic diseases; and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma. The company was founded in October 2004 and is headquartered in San Diego, CA.

Key Statistics

Company Name

TRACON Pharmaceuticals Inc

Average Volume (10 days)

273,442

Average Volume (30 days)

287,488

Moving Average (50 days)

$5.96

Moving Average (200 days)

$4.13

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

0

Market Cap

107,390,622

Shares Outstanding

45,504,501

52-Week High Split Adjust Only

41

52-Week Low Split Adjust Only

2.25

Employee Count

27

Beta

0

Next Earnings Date

2024-05-08

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

-0.54%

Past 30 days

-0.7%

Past 3 months

-0.3%

Past 6 months

-0.39%

Past year

-0.94%

Past 2 years

-0.95%

Past 5 years

-0.98%

Max % Change

-1%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
TRACON Pharmaceuticals IncTCONn/an/a-4.6n/an/a
Peer AvgN/A2.79-1.25-7.32.792.50
Agenus IncAGEN11.18-5.00-4.111.1810.01
Akebia Therapeutics Inc.AKBAn/an/a-2.6n/an/a
Aldeyra Therapeutics IncALDXn/an/a-3.1n/an/a
Affimed N.V.AFMDn/an/a-19.3n/an/a